GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (OTCPK:DSRLF) » Definitions » Cyclically Adjusted PS Ratio

Diasorin SpA (Diasorin SpA) Cyclically Adjusted PS Ratio : 5.96 (As of Apr. 28, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Diasorin SpA Cyclically Adjusted PS Ratio?

As of today (2024-04-28), Diasorin SpA's current share price is $107.40. Diasorin SpA's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $18.02. Diasorin SpA's Cyclically Adjusted PS Ratio for today is 5.96.

The historical rank and industry rank for Diasorin SpA's Cyclically Adjusted PS Ratio or its related term are showing as below:

DSRLF' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 4.95   Med: 9.69   Max: 20.24
Current: 5.64

During the past years, Diasorin SpA's highest Cyclically Adjusted PS Ratio was 20.24. The lowest was 4.95. And the median was 9.69.

DSRLF's Cyclically Adjusted PS Ratio is ranked worse than
75.56% of 135 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.21 vs DSRLF: 5.64

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Diasorin SpA's adjusted revenue per share data for the three months ended in Dec. 2023 was $6.176. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $18.02 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Diasorin SpA Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Diasorin SpA's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diasorin SpA Cyclically Adjusted PS Ratio Chart

Diasorin SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.70 15.97 13.43 8.37 5.54

Diasorin SpA Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.37 6.12 5.86 5.20 5.54

Competitive Comparison of Diasorin SpA's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, Diasorin SpA's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diasorin SpA's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diasorin SpA's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Diasorin SpA's Cyclically Adjusted PS Ratio falls into.



Diasorin SpA Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Diasorin SpA's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=107.40/18.02
=5.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diasorin SpA's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Diasorin SpA's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=6.176/119.5000*119.5000
=6.176

Current CPI (Dec. 2023) = 119.5000.

Diasorin SpA Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 2.693 99.907 3.221
201406 2.769 100.093 3.306
201409 2.637 99.814 3.157
201412 2.650 99.721 3.176
201503 2.319 99.814 2.776
201506 2.607 100.279 3.107
201509 2.509 100.000 2.998
201512 2.593 99.814 3.104
201603 2.522 99.600 3.026
201606 2.909 99.900 3.480
201609 3.013 100.100 3.597
201612 3.005 100.300 3.580
201703 3.076 101.000 3.639
201706 3.319 101.100 3.923
201709 3.252 101.200 3.840
201712 3.608 101.200 4.260
201803 3.661 101.800 4.298
201806 3.560 102.400 4.154
201809 3.473 102.600 4.045
201812 3.647 102.300 4.260
201903 3.531 102.800 4.105
201906 3.705 103.100 4.294
201909 3.518 102.900 4.086
201912 3.675 102.800 4.272
202003 3.521 102.900 4.089
202006 4.270 102.900 4.959
202009 4.901 102.300 5.725
202012 6.025 102.600 7.017
202103 5.798 103.700 6.681
202106 5.473 104.200 6.277
202109 7.377 104.900 8.404
202112 7.817 106.600 8.763
202203 7.198 110.400 7.791
202206 6.393 112.500 6.791
202209 6.014 114.200 6.293
202212 6.912 119.000 6.941
202303 5.794 118.800 5.828
202306 5.831 119.700 5.821
202309 5.407 120.300 5.371
202312 6.176 119.500 6.176

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Diasorin SpA  (OTCPK:DSRLF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Diasorin SpA Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Diasorin SpA's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Diasorin SpA (Diasorin SpA) Business Description

Traded in Other Exchanges
Address
Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040
Diasorin SpA is a biotechnology company engaged in developing, producing, and marketing reagent kits for laboratory diagnostics around the world. The business has focused on the immunodiagnostic market, molecular diagnostics, and Life Science sector. The company has a presence in Italy, Europe, North America, and the Rest of the world, where the majority of its revenue is from North America followed by Italy.